Barclays PLC Cytom X Therapeutics, Inc. Transaction History

Barclays PLC

$377 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.53 - $2.89 $16,107 - $30,425	-10,528 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.67 - $4.68 $182,099 - $319,185	-68,202 Reduced 86.63%	10,528 $28,000
Q4 2021 Feb 14, 2022	SELL	$3.87 - $7.39 $124,316 - $237,388	-32,123 Reduced 28.98%	78,730 $341,000
Q3 2021 Nov 09, 2021	SELL	$4.32 - $6.43 $68,808 - $102,417	-15,928 Reduced 12.56%	110,853 $564,000
Q2 2021 Aug 13, 2021	SELL	$6.33 - $9.91 $66,610 - $104,282	-10,523 Reduced 7.66%	126,781 $802,000
Q1 2021 May 13, 2021	BUY	$6.6 - $9.0 $312,114 - $425,610	47,290 Added 52.54%	137,304 $1.06 Million
Q4 2020 Feb 11, 2021	BUY	$6.47 - $7.9 $391,266 - $477,744	60,474 Added 204.72%	90,014 $589,000
Q3 2020 Nov 12, 2020	SELL	$6.55 - $8.83 $33,549 - $45,227	-5,122 Reduced 14.78%	29,540 $197,000
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $83,583 - $165,358	11,295 Added 48.34%	34,662 $289,000
Q1 2020 May 13, 2020	SELL	$3.61 - $8.6 $111,642 - $265,963	-30,926 Reduced 56.96%	23,367 $179,000
Q4 2019 Feb 10, 2020	BUY	$5.17 - $8.91 $143,591 - $247,466	27,774 Added 104.73%	54,293 $452,000
Q3 2019 Nov 14, 2019	SELL	$7.38 - $12.25 $65,010 - $107,910	-8,809 Reduced 24.93%	26,519 $196,000
Q2 2019 Aug 14, 2019	SELL	$9.35 - $11.41 $47,254 - $57,666	-5,054 Reduced 12.52%	35,328 $397,000
Q1 2019 May 15, 2019	BUY	$9.5 - $19.16 $367,479 - $741,147	38,682 Added 2275.41%	40,382 $434,000
Q4 2018 Feb 14, 2019	SELL	$12.69 - $18.61 $198,243 - $290,725	-15,622 Reduced 90.19%	1,700 $26,000
Q3 2018 Nov 14, 2018	SELL	$18.04 - $26.41 $12,032 - $17,615	-667 Reduced 3.71%	17,322 $321,000
Q2 2018 Aug 14, 2018	BUY	$21.38 - $29.68 $41,840 - $58,083	1,957 Added 12.21%	17,989 $411,000
Q1 2018 May 15, 2018	SELL	$21.76 - $34.22 $105,274 - $165,556	-4,838 Reduced 23.18%	16,032 $457,000
Q4 2017 Feb 14, 2018	SELL	$19.0 - $23.09 $123,804 - $150,454	-6,516 Reduced 23.79%	20,870 $441,000
Q3 2017 Nov 14, 2017	BUY	$13.53 - $18.17 $370,532 - $497,603	27,386	27,386 $497,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.4M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$6.95 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$4.65 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$4.59 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$4.28 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$2.76 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $58.7M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account